As the waistline of Americans has increased, so has the incidence of Type 2 diabetes. Startling data from the Centers for Disease Control  shows that that prevalence of this disease, […]

Two diabetes drugs survived a meeting of the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee on Tuesday. Rejecting recommendations from critics that the drugs should either be withdrawn or get new restrictions on use, […]

WALTHAM, Mass. & SHANGHAI–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has received market authorization from […]

A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. Reuters/Srdjan Zivulovic (Reuters) – The World Health Organization called on Tuesday for the […]

A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. Reuters/Phil Noble (Reuters) – AstraZeneca Plc’s diabetes drug Onglyza and Takeda Pharmaceutical Co.’s rival product […]

An ash tray with cigarette butts is pictured in Hinzenbach, in the Austrian province of Upper Austria, February 5, 2012. Reuters/Lisi Niesner (Reuters) – A group of tobacco companies sued […]

Health | Wed Apr 15, 2015 2:59am EDT MUMBAI | BY ZEBA SIDDIQUI (Reuters) – India may go to the World Trade Organisation (WTO) if the European Union does not reconsider its decision to […]

Frost & Sullivan’s Life Sciences consultants have named seven developmental compounds as the most promising therapeutics to watch in 2015. Puma Biotechnology Inc.’s tyrosine kinase inhibitorneratinib, for extended adjuvant treatment […]

The global EPO market is expected to reach $11.9 billion by 2020, with promising CAGR of 9.7 percentfrom 2014 to 2020, according to a report by Allied Market Research (alliedmarketresearch.com). […]